Moderna
MRNA
#1021
Rank
HK$150.37 B
Marketcap
HK$390.76
Share price
-2.95%
Change (1 day)
-32.16%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

P/S ratio for Moderna (MRNA)

P/S ratio as of November 2024 (TTM): 3.88

According to Moderna 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.65. At the end of 2024 the company had a P/S ratio of 9.12.

P/S ratio history for Moderna from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20249.1262.51%
20235.6153.56%
20223.66-37.03%
20215.81-96.15%
20201519.95%
2019137235.08%
201840.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
4.10 5.60%๐Ÿ‡บ๐Ÿ‡ธ USA
10.4 168.49%๐Ÿ‡บ๐Ÿ‡ธ USA
16.8 332.10%๐Ÿ‡บ๐Ÿ‡ธ USA
4.29 10.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
135 3,388.93%๐Ÿ‡บ๐Ÿ‡ธ USA
4.30 10.93%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA